The Manila Times10 分钟
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
In April 2024, Barinthus Bio announced topline results from the Phase 1b/2 APOLLO dose-ranging trial (also known as HPV001) ...